96 related articles for article (PubMed ID: 27861472)
1. [Rheumatoid arthritis (RA) disease activity predicts function of ABCB1 (P-gp) and ABCG2 (BCRP1) drug-efflux transporters].
Pascual-Ramos V; Atisha-Fregoso Y; Lima G; Fragoso-Loyo H; Jákez-Ocampo J; Contreras-Yáñez I; Llorente L
Gac Med Mex; 2016; 152(6):582-586. PubMed ID: 27861472
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function.
Atisha-Fregoso Y; Lima G; Pascual-Ramos V; Baños-Peláez M; Fragoso-Loyo H; Jakez-Ocampo J; Contreras-Yáñez I; Llorente L
PLoS One; 2016; 11(7):e0159556. PubMed ID: 27442114
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Lymphocyte Multidrug Resistance Activity as a Predictive Tool of Biological Therapeutic Response in Rheumatoid Arthritis.
Toldi G; Batel P; Baráth S; Szerémy P; Apjok A; Filkor K; Szántó S; Szűcs G; Szamosi S; Häupl T; Grützkau A; Szekanecz Z
J Rheumatol; 2019 Jun; 46(6):572-578. PubMed ID: 30709954
[TBL] [Abstract][Full Text] [Related]
4. IL-17A upregulates P-glycoprotein expression in peripheral blood lymphocytes of patients with rheumatoid arthritis through TAK1.
Li Z; Niu H; Yao H; Chen M; Zhao X; Zhao W; Luo J; Gao C; Li X; Wang C
Clin Exp Rheumatol; 2020; 38(2):299-305. PubMed ID: 31376257
[TBL] [Abstract][Full Text] [Related]
5. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis.
Tsujimura S; Saito K; Nawata M; Nakayamada S; Tanaka Y
Ann Rheum Dis; 2008 Mar; 67(3):380-8. PubMed ID: 17660216
[TBL] [Abstract][Full Text] [Related]
6. Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone.
Maillefert JF; Maynadie M; Tebib JG; Aho S; Walker P; Chatard C; Dulieu V; Bouvier M; Carli PM; Tavernier C
Br J Rheumatol; 1996 May; 35(5):430-5. PubMed ID: 8646432
[TBL] [Abstract][Full Text] [Related]
7. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
8. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
[TBL] [Abstract][Full Text] [Related]
9. Relevance of P-glycoprotein on CXCR4
Tsujimura S; Adachi T; Saito K; Kawabe A; Tanaka Y
Mod Rheumatol; 2018 Mar; 28(2):276-286. PubMed ID: 28696805
[TBL] [Abstract][Full Text] [Related]
10. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
11. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters.
Berveiller P; Mir O; Degrelle SA; Tsatsaris V; Selleret L; Guibourdenche J; Evain-Brion D; Fournier T; Gil S
Invest New Drugs; 2019 Oct; 37(5):1075-1085. PubMed ID: 30367323
[TBL] [Abstract][Full Text] [Related]
13. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
[TBL] [Abstract][Full Text] [Related]
15. The effect of Bcrp1 (Abcg2) on the in vivo pharmacokinetics and brain penetration of imatinib mesylate (Gleevec): implications for the use of breast cancer resistance protein and P-glycoprotein inhibitors to enable the brain penetration of imatinib in patients.
Breedveld P; Pluim D; Cipriani G; Wielinga P; van Tellingen O; Schinkel AH; Schellens JH
Cancer Res; 2005 Apr; 65(7):2577-82. PubMed ID: 15805252
[TBL] [Abstract][Full Text] [Related]
16. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
[TBL] [Abstract][Full Text] [Related]
17. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
[TBL] [Abstract][Full Text] [Related]
18. Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs.
van der Heijden J; de Jong MC; Dijkmans BA; Lems WF; Oerlemans R; Kathmann I; Scheffer GL; Scheper RJ; Assaraf YG; Jansen G
Ann Rheum Dis; 2004 Feb; 63(2):131-7. PubMed ID: 14722200
[TBL] [Abstract][Full Text] [Related]
19. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
van der Heijden JW; Oerlemans R; Tak PP; Assaraf YG; Kraan MC; Scheffer GL; van der Laken CJ; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
Arthritis Rheum; 2009 Mar; 60(3):669-77. PubMed ID: 19248091
[TBL] [Abstract][Full Text] [Related]
20. [Multi-drug resistance in the treatments of autoimmune diseases].
Tanaka Y; Tsujimura S
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Oct; 29(5):319-24. PubMed ID: 17075191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
